IRVINE, Calif., Feb. 20, 2018 /PRNewswire/ -- Cryoport, Inc.
(NASDAQ: CYRX), (NASDAQ: CYRXW) ("Cryoport" or "the Company"), the
world's leading temperature controlled logistics company dedicated
to the life sciences industry, today announced that the Company
will report financial results for the fourth quarter and fiscal
year ended December 31, 2017 on
Tuesday, March 6, 2018 after U.S.
financial markets close. Cryoport's senior management will
host a conference call at 4:30 pm ET
on March 6, 2018 to discuss the
financial results, review recent corporate developments and provide
a general business outlook.
Conference Call Information
Date:
|
Tuesday, March 6,
2018
|
Time:
|
4:30 p.m.
ET
|
Dial-in
numbers:
|
+1 (877) 407-9716
(U.S.) or +1 (201) 493-6779 (International)
|
Confirmation
code:
|
Request "Cryoport
Call"
|
Live
webcast:
|
'Investor Relations'
section at www.cryoport.com or at this link. Please allow 10
minutes prior to the call to visit this site to download and
install any necessary audio software.
|
An archive of the webcast will be available approximately three
hours after completion of the live event and will be accessible on
the Investor Relations section of the Company's website at
www.cryoport.com for a limited time. To access the replay of
the webcast, please follow this link. A dial-in replay of the call
will also be available to those interested until March 13, 2018. To access the replay, dial
1 (844) 512-2921 (United States)
or 1 (412) 317-6671 (International) and enter replay pin number:
13676420.
About Cryoport, Inc.
Cryoport is the life sciences industry's most trusted global
provider of temperature-controlled logistics solutions for
temperature-sensitive life sciences commodities, serving the
biopharmaceutical market with leading-edge logistics solutions for
biologic materials, such as regenerative medicine, including
immunotherapies, stem cells and CAR-T cells. Cryoport's solutions
are used by points-of-care, CRO's, central laboratories,
pharmaceutical companies, manufacturers, university researchers et
al; as well as the reproductive medicine market, primarily in IVF
and surrogacy; and the animal health market, primarily in the areas
of vaccines and reproduction. Cryoport's proprietary Cryoport
Express® Shippers, Cryoportal™ Logistics Management
Platform, leading-edge SmartPak II™ Condition Monitoring System and
geo-sensing technology, paired with unparalleled cold chain
logistics expertise and 24/7 client support, make Cryoport the
end-to-end cold chain logistics partner that the industry
trusts.
Cryoport is dedicated to
- simplifying global cold chain logistics through innovative
technology, unmatched monitoring and data capture and support,
including consulting;
- delivering the most advanced temperature controlled logistics
solutions for the life sciences industry; and
- providing vital information that provides peace of mind
throughout the life of each logistics process.
For more information, visit www.cryoport.com. Sign up to follow
@cryoport on Twitter at www.twitter.com/cryoport.
Forward Looking Statements
Statements in this news release which are not purely
historical, including statements regarding Cryoport, Inc.'s
intentions, hopes, beliefs, expectations, representations,
projections, plans or predictions of the future are forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. It is important to note that the Company's
actual results could differ materially from those in any such
forward-looking statements. Factors that could cause actual results
to differ materially include, but are not limited to, risks and
uncertainties associated with the effect of changing economic
conditions, trends in the products markets, variations in the
Company's cash flow, market acceptance risks, and technical
development risks. The Company's business could be affected by a
number of other factors, including the risk factors listed from
time to time in the Company's SEC reports including, but not
limited to, the Transition Report on Form 10-K for the nine months
ended December 31, 2016 filed with
the SEC. The Company cautions investors not to place undue reliance
on the forward-looking statements contained in this press release.
Cryoport, Inc. disclaims any obligation, and does not undertake to
update or revise any forward-looking statements in this press
release.
View original content with
multimedia:http://www.prnewswire.com/news-releases/cryoport-to-report-fourth-quarter-and-fiscal-year-2017-financial-results-on-march-6th-2018-300600701.html
SOURCE Cryoport, Inc.